Dose-ranging Study to Evaluate the Effectiveness and Tolerability of MK0736 in Patients With Type 2 Diabetes Mellitus (T2DM) and Hypertension (0736-007)
Clinical trial NCT00806585 · TERMINATED
Trial details
- NCT number
- NCT00806585
- Sponsor
- Merck Sharp & Dohme LLC
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2008-12-01
- Primary completion
- 2010-03-01
- Enrollment
- 620
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.